Oxford University Innovation’s Clinical Outcomes manages the provision (licensing) and support of high quality clinical outcome assessments (COA) developed at the University of Oxford and elsewhere. The vast majority of our measures are Patient Reported Outcome (PRO) Measures (or sometimes referred to as PROMs).
We provide licences for some of the most respected and widely deployed outcome measures used by the pharmaceutical industry, healthcare providers, academia and medical device manufacturers.
The Clinical Outcomes team can also provide expert advice on the development and psychometric validation of new COAs and PROs, as well as the use of our own and other health outcome measures.
OUI to attend Global Access to Medicines networking evening. The event seeks to catalyse the process of developing medicines that are available and affordable universally.
The Clinical Outcomes team at Oxford University Innovation are very pleased to announce the launch of a standardised instrument used to detect math anxiety as early as possible and help monitor the condition at regular intervals.
Oxford University Innovation's Clinical Outcome team will be attending the annual ISPOR Europe 2019 conference in Copenhagen, Denmark from the 2nd - 6th November 2019.
